273 related articles for article (PubMed ID: 18411399)
21. Expression profiles of metabolic enzymes and drug transporters in the liver and along the intestine of beagle dogs.
Haller S; Schuler F; Lazic SE; Bachir-Cherif D; Krämer SD; Parrott NJ; Steiner G; Belli S
Drug Metab Dispos; 2012 Aug; 40(8):1603-10. PubMed ID: 22596220
[TBL] [Abstract][Full Text] [Related]
22. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
Tang C; Lin JH; Lu AY
Drug Metab Dispos; 2005 May; 33(5):603-13. PubMed ID: 15673596
[TBL] [Abstract][Full Text] [Related]
23. Transporters and drug therapy: implications for drug disposition and disease.
Ho RH; Kim RB
Clin Pharmacol Ther; 2005 Sep; 78(3):260-77. PubMed ID: 16153397
[TBL] [Abstract][Full Text] [Related]
24. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes.
Richert L; Tuschl G; Abadie C; Blanchard N; Pekthong D; Mantion G; Weber JC; Mueller SO
Toxicol Appl Pharmacol; 2009 Feb; 235(1):86-96. PubMed ID: 19118567
[TBL] [Abstract][Full Text] [Related]
25. Utility of a novel Oatp1b2 knockout mouse model for evaluating the role of Oatp1b2 in the hepatic uptake of model compounds.
Chen C; Stock JL; Liu X; Shi J; Van Deusen JW; DiMattia DA; Dullea RG; de Morais SM
Drug Metab Dispos; 2008 Sep; 36(9):1840-5. PubMed ID: 18556442
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction.
Girault I; Rougier N; Chesné C; Lidereau R; Beaune P; Bieche I; de Waziers I
Drug Metab Dispos; 2005 Dec; 33(12):1803-10. PubMed ID: 16135659
[TBL] [Abstract][Full Text] [Related]
27. Implications of hepatic cytochrome P450-related biotransformation processes in veterinary sciences.
Fink-Gremmels J
Eur J Pharmacol; 2008 May; 585(2-3):502-9. PubMed ID: 18417118
[TBL] [Abstract][Full Text] [Related]
28. Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues.
Nakamura K; Fujiki T; Tamura HO
Exp Eye Res; 2005 Dec; 81(6):710-5. PubMed ID: 15967433
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced changes in P450 enzyme expression at the gene expression level: a new dimension to the analysis of drug-drug interactions.
Lee MD; Ayanoglu E; Gong L
Xenobiotica; 2006; 36(10-11):1013-80. PubMed ID: 17118918
[TBL] [Abstract][Full Text] [Related]
30. Biotransformation of drugs in human skin.
Svensson CK
Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism.
Kalsotra A; Strobel HW
Pharmacol Ther; 2006 Dec; 112(3):589-611. PubMed ID: 16926051
[TBL] [Abstract][Full Text] [Related]
32. Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents.
Lu H; Klaassen C
Peptides; 2006 Apr; 27(4):850-7. PubMed ID: 16202478
[TBL] [Abstract][Full Text] [Related]
33. Role of organic cation transporters in the ocular disposition of its intravenously injected substrate in rabbits: implications for ocular drug therapy.
Nirmal J; Sirohiwal A; Singh SB; Biswas NR; Thavaraj V; Azad RV; Velpandian T
Exp Eye Res; 2013 Nov; 116():27-35. PubMed ID: 23892056
[TBL] [Abstract][Full Text] [Related]
34. Expression of multi-drug resistance 1 mRNA in human and rodent tissues: reduced levels in Parkinson patients.
Westerlund M; Belin AC; Olson L; Galter D
Cell Tissue Res; 2008 Nov; 334(2):179-85. PubMed ID: 18855017
[TBL] [Abstract][Full Text] [Related]
35. Interaction of imatinib with human organic ion carriers.
Hu S; Franke RM; Filipski KK; Hu C; Orwick SJ; de Bruijn EA; Burger H; Baker SD; Sparreboom A
Clin Cancer Res; 2008 May; 14(10):3141-8. PubMed ID: 18483382
[TBL] [Abstract][Full Text] [Related]
36. Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
Lee JH; Oh JM; Lee MG
Arch Pharm Res; 2008 Aug; 31(8):951-64. PubMed ID: 18787780
[TBL] [Abstract][Full Text] [Related]
37. Coordinated induction of drug transporters and phase I and II metabolism in human liver slices.
Olinga P; Elferink MG; Draaisma AL; Merema MT; Castell JV; Pérez G; Groothuis GM
Eur J Pharm Sci; 2008 Apr; 33(4-5):380-9. PubMed ID: 18328680
[TBL] [Abstract][Full Text] [Related]
38. Surgical and pharmacological animal models used in drug metabolism and pharmacokinetics.
Landskroner KA; Hess P; Treiber A
Xenobiotica; 2011 Aug; 41(8):687-700. PubMed ID: 21486193
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the modulation of P-glycoprotein (P-gp) on the intraocular disposition of its substrate in rabbits.
Senthilkumari S; Velpandian T; Biswas NR; Saxena R; Ghose S
Curr Eye Res; 2008 Apr; 33(4):333-43. PubMed ID: 18398708
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies.
Kanebratt KP; Andersson TB
Drug Metab Dispos; 2008 Jul; 36(7):1444-52. PubMed ID: 18385292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
